Smith & Nephew SNATS Common Stock Net 2010-2025 | SNN

Smith & Nephew SNATS common stock net for the quarter ending June 30, 2025 was $175M, a 0% increase year-over-year.

  • Smith & Nephew SNATS common stock net for 2024 was $0.175B, a 0% decline from 2023.
  • Smith & Nephew SNATS common stock net for 2023 was $0.175B, a 0% decline from 2022.
  • Smith & Nephew SNATS common stock net for 2022 was $0.175B, a 1.13% decline from 2021.

Smith & Nephew SNATS Common Stock Net 2010-2025 | SNN

  • Smith & Nephew SNATS common stock net for 2024 was $0.175B, a 0% decline from 2023.
  • Smith & Nephew SNATS common stock net for 2023 was $0.175B, a 0% decline from 2022.
  • Smith & Nephew SNATS common stock net for 2022 was $0.175B, a 1.13% decline from 2021.
Related Stocks
Company NameMarket
Cap
Abbott Laboratories (ABT)$228.6B
Boston Scientific (BSX)$156.7B
Stryker (SYK)$149B
EssilorLuxottica (ESLOY)$142.5B
Medtronic (MDT)$118B
Lonza Group Ag (LZAGY)$49.9B
Haleon (HLN)$43.5B
ResMed (RMD)$40.3B
Agilent Technologies (A)$35.5B
GE HealthCare Technologies (GEHC)$33.7B
Terumo (TRUMY)$26.8B
Koninklijke Philips (PHG)$26.6B
Insulet (PODD)$23.8B
Zimmer Biomet Holdings (ZBH)$20.8B
Baxter (BAX)$12.5B
Sunny Optical Technology (SNPTF)$10.8B
Demant (WILYY)$8.1B
Bio-Rad Laboratories (BIO)$7.9B
Lantheus Holdings (LNTH)$3.8B
Envista Holdings (NVST)$3.5B
Shandong Weigao Medical Polymer (SHWGF)$3.5B
Prestige Consumer Healthcare (PBH)$3.3B
Perrigo (PRGO)$3.3B
ICU Medical (ICUI)$3.1B
Haemonetics (HAE)$2.6B
Curaleaf Holdings (CURLF)$2.3B
Acuren (TIC)$2.2B
LeMaitre Vascular (LMAT)$2.2B
QuidelOrtho (QDEL)$1.9B
Green Thumb Industries (GTBIF)$1.9B